07/07/2015
http://www.endocrineweb.com/news/diabetes/15021-whats-behind-fdas-warning-about-diabetic-ketoacidosis-sglt2-inhibitors
More on the harmful side effects of inhibitors that are being used to treat
A recent, headline-grabbing warning from the U.S. Food and Drug Administration (FDA) warned people with diabetes who take blood sugar-lowering drugs called SGLT2 inhibitors, saying they should watch for signs of a life-threatening condition called diabetic ketoacidosis.